These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32087263)

  • 1. 3D printed opioid medicines with alcohol-resistant and abuse-deterrent properties.
    Ong JJ; Awad A; Martorana A; Gaisford S; Stoyanov E; Basit AW; Goyanes A
    Int J Pharm; 2020 Apr; 579():119169. PubMed ID: 32087263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction.
    Nukala PK; Palekar S; Patki M; Patel K
    AAPS PharmSciTech; 2019 Jan; 20(2):80. PubMed ID: 30645704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition modelling (FDM) 3D printer.
    Palekar S; Nukala PK; Patel K
    Int J Pharm; 2022 Jun; 621():121804. PubMed ID: 35533922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Drug Release Testing to Evaluate the Retention of Abuse-Deterrent Properties of Polyethylene Oxide Matrix Tablets.
    Meruva S; Rezaei L; Thool P; Donovan MD
    AAPS PharmSciTech; 2020 Oct; 21(7):270. PubMed ID: 33025237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-deterrent features of an extended-release morphine drug product developed using a novel injection-molding technology for oral drug delivery.
    Skak N; Elhauge T; Dayno JM; Lindhardt K
    J Opioid Manag; 2017; 13(6):465-472. PubMed ID: 29308592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process.
    Goyanes A; Allahham N; Trenfield SJ; Stoyanov E; Gaisford S; Basit AW
    Int J Pharm; 2019 Aug; 567():118471. PubMed ID: 31252147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets.
    Eisenhauer TD; Matchett M; Heasley R; Morton T; Devarakonda K; Giuliani M; Young JL; Barrett T
    Drug Dev Ind Pharm; 2016 Jan; 42(1):157-165. PubMed ID: 26146769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
    Gasior M; Bond M; Malamut R
    Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse-deterrent Opioid Formulations.
    Litman RS; Pagán OH; Cicero TJ
    Anesthesiology; 2018 May; 128(5):1015-1026. PubMed ID: 29252508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of hot-melt extrusion technology in immediate-release abuse-deterrent formulations.
    Wening K; Schwier S; Stahlberg HJ; Galia E
    J Opioid Manag; 2017; 13(6):473-484. PubMed ID: 29308593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in abuse-deterrent technologies for the delivery of opioids.
    Maincent J; Zhang F
    Int J Pharm; 2016 Aug; 510(1):57-72. PubMed ID: 27291971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(vinyl alcohol) 3D printed tablets: The effect of polymer particle size on drug loading and process efficiency.
    Saviano M; Aquino RP; Del Gaudio P; Sansone F; Russo P
    Int J Pharm; 2019 Apr; 561():1-8. PubMed ID: 30817983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Abuse-Deterrent formulations utilizing Ion-Exchange resin complexation processed via Twin-Screw granulation for improved safety and effectiveness.
    Ram Munnangi S; Narala N; Lakkala P; Kumar Vemula S; Repka M
    Eur J Pharm Biopharm; 2024 Apr; 197():114230. PubMed ID: 38373555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Impact and Application of Abuse-Deterrent Opioid Formulations in Clinical Practice.
    Lee YH; Brown DL; Chen HY
    Pain Physician; 2017 Nov; 20(7):E1003-E1023. PubMed ID: 29149148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets.
    Rahman Z; Zidan AS; Korang-Yeboah M; Yang Y; Siddiqui A; Shakleya D; Khan MA; Cruz C; Ashraf M
    Int J Pharm; 2017 Jan; 517(1-2):303-311. PubMed ID: 27956191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential Oxycodone Loss of Physically Manipulated Abuse Deterrent Oxycodone HCl Extended Release Tablets Prepared for Nasal Insufflation Studies.
    Meng Z; Boyce HJ; Sun D; Kinjo M; Raofi S; Li T
    Pharm Res; 2021 Jul; 38(7):1263-1278. PubMed ID: 34128146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid extended-release tablets with improved tamper-resistant properties.
    Bartholomaeus JH; Arkenau-Marić E; Galia E
    Expert Opin Drug Deliv; 2012 Aug; 9(8):879-91. PubMed ID: 22690792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.